A phase 3 trial of inotuzumab ozogamicin for high-risk B-ALL: Second safety phase results from Children's Oncology Group AALL1732

被引：0
|
作者：
O'Brien, Maureen Megan
McNeer, Jennifer Lynn
Rheingold, Susan R.
Devidas, Meenakshi
Chen, Zhiguo
Bhojwani, Deepa
Ramsey, Laura B.
Agrawal, Anurag
Wood, Brent L.
Suh, Eugene
Alexander, Sarah
Miller, Tamara P.
Militano, Olga
Burke, Michael
Salzer, Wanda L.
Raetz, Elizabeth A.
Loh, Mignon L.
机构：
[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA
[2] Univ Chicago, Chicago, IL USA
[3] Childrens Hosp Philadelphia, Philadelphia, PA USA
[4] St Jude Childrens Res Hosp, Memphis, TN USA
[5] Univ Florida, Dept Biostat, Gainesville, FL USA
[6] Childrens Hosp Los Angeles, Los Angeles, CA USA
[7] UCSF, Benioff Childrens Hosp Oakland, Oakland, CA USA
[8] CHLA, Los Angeles, CA USA
[9] Loyola Univ, Med Ctr, Maywood, IL USA
[10] Hosp Sick Children, Toronto, ON, Canada
[11] Emory Univ, Atlanta, GA USA
[12] Childrens Oncol Grp, Monrovia, CA USA
[13] Med Coll Wisconsin, Milwaukee, WI USA
[14] Uniformed Serv Univ Hlth Sci, Bethesda, MD USA
[15] Perlmutter Canc Ctr, New York, NY USA
[16] NYU Langone, New York, NY USA
[17] Seattle Childrens Hosp, Seattle, WA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10016
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Phase 3 Randomized Trial of Inotuzumab Ozogamicin for Newly Diagnosed High-Risk B-ALL: Safety Phase Results from Children's Oncology Group Protocol AALL1732
    McNeer, Jennifer L.
    O'Brien, Maureen M.
    Rheingold, Susan R.
    Devidas, Meenakshi
    Chen, Zhiguo
    Bhojwani, Deepa
    Agrawal, Anurag K.
    Wood, Brent
    Suh, Eugene
    Alexander, Sarah
    Miller, Tamara P.
    Militano, Olga
    Raetz, Elizabeth A.
    Loh, Mignon L.
    BLOOD, 2021, 138
  • [2] A Phase 2 Trial of Inotuzumab Ozogamicin (InO) in Children and Young Adults with Relapsed or Refractory (R/R) CD22+B-Acute Lymphoblastic Leukemia (B-ALL): Results from Children's Oncology Group Protocol AALL1621
    O'Brien, Maureen M.
    Ji, Lingyun
    Shah, Nirali N.
    Rheingold, Susan R.
    Bhojwani, Deepa
    Yi, Joanna S.
    Yuan, Constance M.
    Harris, Andrew C.
    Brown, Patrick A.
    Borowitz, Michael J.
    Militano, Olga
    Devidas, Meenakshi
    Raetz, Elizabeth A.
    Gore, Lia
    Loh, Mignon L.
    BLOOD, 2019, 134
  • [3] Development of osteonecrosis and improved survival in B-ALL: results of Children's Oncology Group Trial AALL0232
    Mattano Jr, Leonard A.
    Devidas, Meenakshi
    Loh, Mignon L.
    Raetz, Elizabeth A.
    Chen, Zhiguo
    Winick, Naomi J.
    Hunger, Stephen P.
    Carroll, William L.
    Larsen, Eric C.
    LEUKEMIA, 2023, 38 (2) : 258 - 265
  • [4] Development of osteonecrosis and improved survival in B-ALL: results of Children’s Oncology Group Trial AALL0232
    Leonard A. Mattano
    Meenakshi Devidas
    Mignon L. Loh
    Elizabeth A. Raetz
    Zhiguo Chen
    Naomi J. Winick
    Stephen P. Hunger
    William L. Carroll
    Eric C. Larsen
    Leukemia, 2024, 38 : 258 - 265
  • [5] Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol AALL1621
    O'Brien, Maureen M.
    Ji, Lingyun
    Shah, Nirali N.
    Rheingold, Susan R.
    Bhojwani, Deepa
    Yuan, Constance M.
    Xu, Xinxin
    Yi, Joanna S.
    Harris, Andrew C.
    Brown, Patrick A.
    Borowitz, Michael J.
    Militano, Olga
    Kairalla, John
    Devidas, Meenakshi
    Raetz, Elizabeth A.
    Gore, Lia
    Loh, Mignon L.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (09) : 956 - 967
  • [6] Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group
    Reshmi, Shalini C.
    Harvey, Richard C.
    Roberts, Kathryn G.
    Stonerock, Eileen
    Smith, Amy
    Jenkins, Heather
    Chen, I-Ming
    Valentine, Marc
    Liu, Yu
    Li, Yongjin
    Shao, Ying
    Easton, John
    Payne-Turner, Debbie
    Gu, Zhaohui
    Thai Hoa Tran
    Nguyen, Jonathan V.
    Devidas, Meenakshi
    Dai, Yunfeng
    Heerema, Nyla A.
    Carroll, Andrew J., III
    Raetz, Elizabeth A.
    Borowitz, Michael J.
    Wood, Brent L.
    Angiolillo, Anne L.
    Burke, Michael J.
    Salzer, Wanda L.
    Zweidler-McKay, Patrick A.
    Rabin, Karen R.
    Carroll, William L.
    Zhang, Jinghui
    Loh, Mignon L.
    Mullighan, Charles G.
    Willman, Cheryl L.
    Gastier-Foster, Julie M.
    Hunger, Stephen P.
    BLOOD, 2017, 129 (25) : 3352 - 3361
  • [7] Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232
    Borowitz, Michael J.
    Wood, Brent L.
    Devidas, Meenakshi
    Loh, Mignon L.
    Raetz, Elizabeth A.
    Salzer, Wanda L.
    Nachman, James B.
    Carroll, Andrew J.
    Heerema, Nyla A.
    Gastier-Foster, Julie M.
    Willman, Cheryl L.
    Dai, Yunfeng
    Winick, Naomi J.
    Hunger, Stephen P.
    Carroll, William L.
    Larsen, Eric
    BLOOD, 2015, 126 (08) : 964 - 971
  • [8] Evaluation of CD22 modulation as a mechanism of resistance to inotuzumab ozogamicin (InO): Results from central CD22 testing on the Children's Oncology Group (COG) phase II trial of INO in children and young adults with CD22+B-acute lymphoblastic leukemia (B-ALL).
    Shah, Nirali N.
    O'Brien, Maureen Megan
    Yuan, Constance
    Ji, Lingyun
    Xu, Xinxin
    Rheingold, Susan R.
    Bhojwani, Deepa
    Yi, Joanna
    Harris, Andrew
    Brown, Patrick A.
    Borowitz, Michael J.
    Devidas, Meenakshi
    Raetz, Elizabeth A.
    Gore, Lia
    Loh, Mignon L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse
    Hogan, Laura E.
    Brown, Patrick A.
    Ji, Lingyun
    Xu, Xinxin
    Devidas, Meenakshi
    Bhatla, Teena
    Borowitz, Michael J.
    Raetz, Elizabeth A.
    Carroll, Andrew
    Heerema, Nyla A.
    Zugmaier, Gerhard
    Sharon, Elad
    Bernhardt, Melanie B.
    Terezakis, Stephanie A.
    Gore, Lia
    Whitlock, James A.
    Hunger, Stephen P.
    Loh, Mignon L.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (25) : 4118 - +
  • [10] Phase I trial of oral fenretinide in children with high-risk solid tumors: A report from the Children's Oncology Group (CCG 09709)
    Villablanca, Judith G.
    Krailo, Mark D.
    Ames, Matthew M.
    Reid, Joel M.
    Reaman, Gregory H.
    Reynolds, Patrick C.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (21) : 3423 - 3430
12345